4-Bromo-1-ethyl-3-(4-nitrophenyl)-1H-pyrazole, 98%, 1g

Methyl 2-chloro-5-methoxybenzoate, 95.0%, 10g

1-[(4-methoxyphenyl)methyl]-1H,4H,7H-pyrazolo[3,4-b]pyridin-4-one, 97%, 5g

5-Bromo-2-chloro-3-nitropyridine, 97.0%, 10g

2-Amino-4-bromo-7-fluorobenzo[b]thiophene-3-carbonitrile, 98%, 250mg

Silver(II) Pyridine-2-carboxylate>97.0%(T)5g

5-chloro-6-nitro-1H-indole, 95.0%, 10g

8-Bromonaphthalen-1-amine, 97%, 10g

Flacon récepteur, 500 ml, 1 pièce

6-Bromo-3-chloropyridin-2(1H)-one, 97%, 100mg

(R)-3-Amino-3-(4-methoxyphenyl)propanoic acid, 97%, 1g

Plateaux d'incubation occidentaux, MIDI, 10 pièce(s)

3-Bromo-4-(tert-butyl)aniline, 95.0%, 250mg